医学
肾脏疾病
肾功能
内科学
危险系数
队列
比例危险模型
人口
队列研究
认知
萧条(经济学)
流行病学
认知功能衰退
疾病
置信区间
精神科
痴呆
经济
宏观经济学
环境卫生
作者
Marion Pépin,Hélène Levassort,Julie Boucquemont,Oriane Lambert,Natália Alencar de Pinho,Monica Turinici,Catherine Helmer,Marie Essig,Lynda Cheddani,Luc Frimat,Christian Combe,Denis Fouque,Maurice Laville,Carole Ayav,Sophie Liabeuf,Christian Jacquelinet,Laurent Teillet,Bénédicte Stengel,Sophie Liabeuf
标识
DOI:10.1136/jnnp-2022-330347
摘要
Background Chronic kidney disease (CKD) is associated with cognitive impairment in general population. We assessed the association between kidney and cognitive functions in patients with CKD and the influence of cardiovascular (CV) risk factors, and depression on this association. Methods The CKD-Renal Epidemiology and Information Network cohort included 3033 patients with CKD stages 3–4, followed for 5 years. Cognitive function was assessed with the Mini-Mental State Examination (MMSE) and estimated glomerular filtration rate (eGFR) with the CKD-Epidemiology Collaboration equation-creatinin formula. Evolution of the MMSE score over time and its association with baseline eGFR were investigated with linear mixed models. We assessed the risk of incident cognitive outcome (hospitalisation or death with relevant International Classification of Disease-10 codes), with a Cox proportional hazard model. Results The mean age was 66.8, the mean eGFR was 33 mL/min/1.73 m 2 and 387 patients (13.0%) had an MMSE score below 24 at baseline. A 10 mL/min/1.73 m 2 decrement of baseline eGFR was associated with a mean MMSE decrease of 0.12 (95% CI 0.04 to 0.19) after adjustment for demographic characteristics, depression, CV risk factors and disease; but baseline eGFR was not associated with MMSE temporal evolution. HR for cognitive outcome during follow-up (median 2.01 years) associated with a 10 mL/min/1.73 m 2 decrement of baseline eGFR was 1.35 (1.07, 1.70) (p=0.01) after adjustment. Conclusions In patients with CKD, lower eGFR was associated with worse cognitive performance and incident cognitive events, independently of demographics, CV risk factors and depression. Trial registration number NCT03381950 .
科研通智能强力驱动
Strongly Powered by AbleSci AI